These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 29492753)

  • 1. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
    Graetz I; McKillop CN; Stepanski E; Vidal GA; Anderson JN; Schwartzberg LS
    J Cancer Surviv; 2018 Aug; 12(4):431-440. PubMed ID: 29492753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
    Paladino AJ; Anderson JN; Krukowski RA; Waters T; Kocak M; Graff C; Blue R; Jones TN; Buzaglo J; Vidal G; Schwartzberg L; Graetz I
    BMC Health Serv Res; 2019 Dec; 19(1):977. PubMed ID: 31856812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
    Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Graetz I; Hu X; Kocak M; Krukowski RA; Anderson JN; Waters TM; Curry AN; Robles A; Paladino A; Stepanski E; Vidal GA; Schwartzberg LS
    JAMA Netw Open; 2024 Jun; 7(6):e2417873. PubMed ID: 38935379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
    Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL
    J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
    Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
    Ernst A; Flynn KE; Weil EM; Crotty BH; Kamaraju S; Fergestrom N; Neuner J
    Clin Breast Cancer; 2021 Feb; 21(1):e38-e47. PubMed ID: 33183969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
    He Y; Tan EH; Wong ALA; Tan CC; Wong P; Lee SC; Tai BC
    BMC Cancer; 2018 Jul; 18(1):727. PubMed ID: 29986672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
    Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
    Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a web-based app to improve postoperative outcomes for patients receiving gynecological oncology care: A randomized controlled feasibility trial.
    Graetz I; Anderson JN; McKillop CN; Stepanski EJ; Paladino AJ; Tillmanns TD
    Gynecol Oncol; 2018 Aug; 150(2):311-317. PubMed ID: 29903391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
    Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
    Breast; 2020 Oct; 53():77-84. PubMed ID: 32652462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors.
    Brier MJ; Chambless D; Gross R; Su HI; DeMichele A; Mao JJ
    Eur J Cancer; 2015 Sep; 51(14):1890-6. PubMed ID: 26169018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer.
    Greer JA; Jacobs JM; Pensak N; Nisotel LE; Fishbein JN; MacDonald JJ; Ream ME; Walsh EA; Buzaglo J; Muzikansky A; Lennes IT; Safren SA; Pirl WF; Temel JS
    J Natl Compr Canc Netw; 2020 Feb; 18(2):133-141. PubMed ID: 32023526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
    Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
    Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
    Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
    BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
    Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
    Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.
    Kesmodel SB; Goloubeva OG; Rosenblatt PY; Heiss B; Bellavance EC; Chumsri S; Bao T; Thompson J; Nightingale G; Tait NS; Nichols EM; Feigenberg SJ; Tkaczuk KH
    Am J Clin Oncol; 2018 May; 41(5):508-512. PubMed ID: 27322700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
    Hershman DL; Unger JM; Hillyer GC; Moseley A; Arnold KB; Dakhil SR; Esparaz BT; Kuan MC; Graham ML; Lackowski DM; Edenfield WJ; Dayao ZR; Henry NL; Gralow JR; Ramsey SD; Neugut AI
    J Clin Oncol; 2020 Jul; 38(19):2122-2129. PubMed ID: 32369401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
    Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
    J Clin Nurs; 2019 Dec; 28(23-24):4560-4571. PubMed ID: 31469461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
    Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.